Bio-Techne Gives FTC More Time On $11.3B Merck Deal
Life science tool company Bio-Techne has withdrawn and refiled its intent to merge with pharmaceutical giant Merck in an $11.3 billion deal in order to give the Federal Trade Commission more...To view the full article, register now.
Already a subscriber? Click here to view full article